SPOTLIGHT -
EP. 1: Strategies for Using Biomarkers in Prostate Cancer
EP. 2: Follow-up Biomarker Testing in Prostate Cancer
EP. 3: Biomarkers for Aiding Risk Stratification and Treatment Decisions
EP. 4: Integrating Molecular Testing Into Urology Practices
EP. 5: ADT in Prostate Cancer: Agonists Versus Antagonists
EP. 6: CHAARTED Trial Changes Practice in Prostate Cancer
EP. 7: Integrating CHAARTED Findings Into Prostate Cancer Care
EP. 8: Pre-Chemotherapy Abiraterone Acetate in CRPC
EP. 9: Enzalutamide Offers Second Option in Pre-Chemo CRPC
EP. 10: Antiandrogen Resistance With AR-V7 in CRPC
EP. 11: Radium-223 for Treatment of Prostate Cancer
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
